DRM02

DRUG3 trials

Sponsors

Dermira, Inc.

Conditions

Atopic DermatitisPsoriasisRosacea

Phase 2

A Safety and Efficacy Study of DRM02 in Subjects With Plaque Psoriasis

CompletedNCT01993433

Dermira, Inc.Psoriasis

Start: 2013-10-31End: 2014-03-31Updated: 2021-07-20

A Safety and Efficacy of DRM02 in Subjects With Atopic Dermatitis

CompletedNCT01993420

Dermira, Inc.Atopic Dermatitis

Start: 2013-10-31End: 2014-03-31Updated: 2021-07-20

A Safety and Efficacy Study of DRM02 in Subjects With Rosacea

CompletedNCT01993446

Dermira, Inc.Rosacea

Start: 2013-10-31End: 2014-03-31Updated: 2021-07-20